An insertion in loop L7 of human eosinophil-derived neurotoxin is crucial for its antiviral activity

Journal of Cellular Biochemistry
Deepa SikriwalJanendra K Batra

Abstract

The human eosinophil granule ribonuclease, eosinophil-derived neurotoxin (EDN) has been shown to have antiviral activity against respiratory syncytial virus-B (RSV-B). Other closely related and more active RNases such as RNase A, onconase, and RNase k6 do not have any antiviral activity. A remarkable unique feature of EDN is a nine-residue insertion in its carboxy-terminal loop, L7 which is not present in RNase A, and differs in sequence from the corresponding loop in another eosinophil RNase, eosinophil cationic protein (ECP). ECP has a much lower antiviral activity as compared to EDN. The current study probed the role of loop L7 of EDN in its antiviral activity. Three residues in loop L7, Arg117, Pro120, and Gln122, which diverge between EDN, ECP, and RNase A, were mutated to alanine alone and in combination to generate single, double, and triple mutants. These mutants, despite having RNase activity had decreased antiviral activity towards RSV suggesting the involvement of loop L7 in the interaction of EDN with RSV. It appears that the mutations in loop L7 disrupt the interaction of protein with the viral capsid, thereby inhibiting its entry into the virions. The study demonstrates that besides the RNase activity, loop L7 is ...Continue Reading

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Aug 15, 1991·Nature·G Natsoulis, J D Boeke
Mar 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·T W HallahanB L Vallee
Jan 1, 1987·Methods in Enzymology·T A KunkelR A Zakour
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·G J GleichD J McKean
Jan 1, 1986·Advances in Immunology·G J Gleich, C R Adolphson
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·K R AcharyaB L Vallee
Jan 1, 1996·Journal of Clinical Microbiology·J GottschalkI Heinzer
Jul 25, 2000·Journal of Molecular Biology·G Mallorquí-FernándezM Coll
Jan 18, 2003·World Journal of Gastroenterology : WJG·Jun LiuYu-Xiao Huang
Apr 1, 1993·Trends in Cell Biology·G D'Alessio
Mar 23, 2006·Annual Review of Immunology·Marc E Rothenberg, Simon P Hogan
May 8, 2007·Molecular and Cellular Biochemistry·Deepa SikriwalJanendra K Batra
Apr 4, 2008·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Simon P HoganMarc E Rothenberg
Sep 17, 2010·Biochimica Et Biophysica Acta·Evandro Fei Fang, Tzi Bun Ng

❮ Previous
Next ❯

Citations

Sep 26, 2013·International Journal of Molecular Sciences·Ta-Jen HungMargaret Dah-Tsyr Chang
Apr 7, 2015·Molekuliarnaia biologiia·O N Il'inskaia, R Shakh Makhmud
Sep 8, 2018·American Journal of Respiratory and Critical Care Medicine·Yanaika S Sabogal PiñerosRené Lutter
Jan 1, 2014·Molecular Biology·O N Ilinskaya, R Shah Mahmud
Jun 6, 2018·Frontiers in Immunology·Lu LuEster Boix

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.